Justin Tannir, MD
Ophthalmology · Traverse City, MINPI 1578740668
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 63.0% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2019 at $11,700 and has fallen 93.1% since, to $808 in 2025. Among ophthalmology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 243 payments — averaging $87.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$13K
- Alcon$2K
- Rxsight Inc$2K
- Johnson & Johnson Surgical Vision, Inc.$998
- Bausch & Lomb Americas Inc.$461
- Genentech USA, Inc.$272
- plus $2K from 24 others
Across 1 payment — averaging $5.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$5
What the payments were for
- Speaking & faculty fees$8,21339%
- Travel & lodging$2,88014%
- Food & beverage$8,56540%
- Education$1,5477%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 70 | $13,368 |
| Alcon | 42 | $1,963 |
| Rxsight Inc | 11 | $1,760 |
| Johnson & Johnson Surgical Vision, Inc. | 19 | $998 |
| Bausch & Lomb Americas Inc. | 10 | $461 |
| Genentech USA, Inc. | 11 | $272 |
| Aerie Pharmaceuticals, Inc. | 6 | $222 |
| Mallinckrodt Enterprises LLC | 3 | $205 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $198 |
| Regeneron Healthcare Solutions, Inc. | 4 | $186 |
| Amgen(2 entities) | 9 | $174 |
| Tarsus Pharmaceuticals, Inc. | 8 | $173 |
| Biotissue Holdings Inc. | 3 | $165 |
| Carl Zeiss Meditec USA, Inc. | 2 | $141 |
| Novartis | 8 | $129 |
| Mallinckrodt Hospital Products Inc. | 1 | $108 |
| Nova Eye, Inc. | 1 | $101 |
| Kala Pharmaceuticals, Inc. | 4 | $89 |
| Sight Sciences, Inc. | 5 | $86 |
| Glaukos Corporation | 3 | $64 |
| Dompe US, Inc. | 3 | $62 |
| NEW World Medical,inc. | 4 | $46 |
| Astellas Pharma US Inc | 2 | $45 |
| Harrow Eye, LLC | 1 | $39 |
| Oyster Point Pharma, Inc. | 2 | $36 |
| Rayner Intraocular Lenses Limited | 1 | $32 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
| Lombart Brothers, Inc. | 1 | $21 |
| Apellis Pharmaceuticals, Inc. | 1 | $18 |
| Ocular Therapeutix, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LUMIGAN$11,521
- COMBIGAN$2,824
- RXSIGHT CONTACT LENS$1,500
- RXSIGHT INJECTOR CARTRIDGE$1,500
- RXSIGHT INJECTOR HANDPIECE$1,500
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$1,500
- LIGHT ADJUSTABLE LENS (LAL)$1,500
- Tecnis IOL$563
- Hydrus Microstent$531
- CATALYS SYSTEM$348
- Centurion$241
- ACTHAR$209
- enVista MX60 IOL$189
- Clareon$131
- EYLEA HD$128
- AcrySof IQ PanOptix UV IOL$118
- LenSx$113
How this compares
$21,204 in reported general payments places this provider in the 95th percentile of 674 ophthalmology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 167 | $82,713 |
| RestasisCyclosporine | 54 | $60,003 |
| Bromfenac Sodium | 159 | $38,233 |
| Bimatoprost | 192 | $28,212 |
| Cyclosporine | 36 | $24,854 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 112 | $22,918 |
| RocklatanNetarsudil Mesylat/Latanoprost | 49 | $21,548 |
| CombiganBrimonidine Tartrate/Timolol | 57 | $20,747 |
| ProlensaBromfenac Sodium | 53 | $17,851 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 64 | $17,152 |
| Travoprost | 79 | $13,467 |
| Brimonidine Tartrate | 322 | $7,294 |
| Restasis MultidoseCyclosporine | 12 | $7,236 |
| Latanoprost | 384 | $6,726 |
| TafluprostTafluprost/Pf | 21 | $6,164 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Restasis, Combigan, Restasis Multidose | $13,368 | $170,700290 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan | $222 | $21,54849 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa | $198 | $17,85153 claims |
| AlconSimbrinza | $1,963 | $17,15264 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 674 ophthalmology providers in Michigan.
Other ophthalmology in Traverse City
- Alicia EbyTraverse City$9K
- Manjool ShahAnn Arbor$609K
- Gregory KatzYpsilanti$401K
- Timothy PageBirmingham$250K
- David ZacksAnn Arbor$177K
- Scott WesthouseGrand Rapids$138K
- Bret HughesDetroit$123K
- Pradeepa YoganathanDetroit$115K
- Jason MillerAnn Arbor$104K
- David TukelDearborn$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.